|
| 37611810 | The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans. | Int J Radiat Oncol Biol Phys | 2024 |
| 36215572 | <sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002. | J Nucl Med | 2023 |
| 37499325 | Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients. | Oral Oncol | 2023 |
| 37498564 | Individualized risk assessment of distant metastases in oral cavity carcinoma: a validated predictive-score model. | J Natl Cancer Inst | 2023 |
| 37266942 | Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. | JAMA Netw Open | 2023 |
| 36653915 | Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. | Cancer | 2023 |
| 36780824 | The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis. | Oral Oncol | 2023 |
| 36416855 | Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 34652823 | Quantifying Neck Fibrosis and Its Functional Implications: Development of the Neck Fibrosis Scale. | Laryngoscope | 2022 |
| 35804877 | Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up. | Cancers (Basel) | 2022 |
| 35588085 | Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. | Cancer | 2022 |
| 35905781 | Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary. | Radiother Oncol | 2022 |
| 36129469 | CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer. | Clin Cancer Res | 2022 |
| 36353565 | Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma. | Front Oncol | 2022 |
| 35315548 | Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer. | Head Neck | 2022 |
| 35038657 | Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma. | Oral Oncol | 2022 |
| 35238880 | Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. | JAMA Otolaryngol Head Neck Surg | 2022 |
| 34792199 | Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. | Int J Cancer | 2022 |
| 33002201 | Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes. | Laryngoscope | 2021 |
| 33600871 | Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy. | Radiother Oncol | 2021 |
| 33508706 | Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma. | Oral Oncol | 2021 |
| 33507809 | Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). | J Clin Oncol | 2021 |
| 33750907 | Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). | Br J Cancer | 2021 |
| 33635537 | Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis. | Cancer | 2021 |
| 33580567 | Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy. | Head Neck | 2021 |
| 33524796 | Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey. | Oral Oncol | 2021 |
| 33856051 | Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck. | Laryngoscope | 2021 |
| 34718052 | Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort. | Radiother Oncol | 2021 |
| 34158359 | Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. | Clin Cancer Res | 2021 |
| 34298857 | Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors. | Cancers (Basel) | 2021 |
| 34062618 | A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer. | Cancer | 2021 |
| 34175612 | Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study. | Oral Oncol | 2021 |
| 34261594 | The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer. | Clin Oncol (R Coll Radiol) | 2021 |
| 33058305 | Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma. | Head Neck | 2021 |
| 33264637 | Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma. | Radiother Oncol | 2021 |
| 32861702 | Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach. | Radiother Oncol | 2021 |
| 31568813 | The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors. | Int J Radiat Oncol Biol Phys | 2020 |
| 32055717 | Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer. | Clin Transl Radiat Oncol | 2020 |
| 31959347 | Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma. | Ann Oncol | 2020 |
| 31710939 | Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification. | Radiother Oncol | 2020 |
| 32778168 | Tracheoesophageal voice prosthesis management in laryngectomy patients during the COVID-19 pandemic. | J Otolaryngol Head Neck Surg | 2020 |
| 32679542 | Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants. | Oral Oncol | 2020 |
| 32730830 | Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. | Radiother Oncol | 2020 |
| 32615441 | Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension. | Oral Oncol | 2020 |
| 32610131 | Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. | Cell Rep | 2020 |
| 32338807 | Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experience. | Head Neck | 2020 |
| 32302681 | Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. | Int J Radiat Oncol Biol Phys | 2020 |
| 32272384 | Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy. | Oral Oncol | 2020 |
| 32496903 | De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies. | J Clin Oncol | 2020 |
| 32464516 | Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. | Oral Oncol | 2020 |